Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HSNCC
K. N. M. Abdelazeem, D. Nguyen, S. Corbo, L. Darragh, M. W. Matsumoto, B. Vancourt, B. Neupert, J. Yu, N. Olimpo, D. G. Osborne, J. Gadwa, R. B. Ross, A. Nguyen, S. Bhatia, M. Kapoor, , S. D. Karam
This study shows that targeting the EphB4-ephrinB2 axis with engineered ligands reduces metastasis in HNSCC by modulating tumor microenvironment and immune responses.
bioRxiv · Jul 21, 2024Cancer Biology